Sandrine M. Miller-Montgomery
Exec Dir/Ctr Microbiome Innov, Office of the Dean of Engineering
Professor of practice, molecular biology, microbiome discovery
Dr. Sandrine Miller-Montgomery is the Executive Director of the Center for Microbiome Innovation, led by Professor Rob Knight at UC San Diego, and serves as a Professor of Practice in the Department of Bioengineering. In this position, she is leading a team focused on fostering and expanding industry and academic collaborations, with the mission of accelerating Microbiome discovery and creating innovative technologies that will support this emerging but exploding field in the consumer world as well as enabling major clinical breakthroughs.
Dr. Miller-Montgomery was previously the CEO of MO BIO Laboratories, a QIAGEN Company, focusing on nucleic acid purification solutions for challenging samples, such as ones found in Microbiome studies. Prior to heading the MO BIO site, she was their Director of Sales and Marketing, where she led a team, which consistently grew the business at a rate far superior to the market rate. She assisted the two original founders and private owners of the company to sell the company when they decided to retire, resulting into its acquisition by QIAGEN, the market leader in Nucleic Acid Sample Preparation.
She has held Global Marketing Manager positions at large companies such as Abbott Laboratories or Illumina (following the acquisition of Helixis, a startup which she had joined in 2008, as lucky employee 13, to help with the commercialization of their innovative qPCR platform and their exit strategy). Before Helixis, Dr. Miller-Montgomery had worked for many years at Invitrogen, now part of Thermo Fisher, where she started as a bench scientist, moved up as the R&D Manager, then became one of their first Program Managers and ultimately migrated to the business side as Product Manager for both qPCR reagents and Reverse Transcriptase portfolio.
Dr. Miller-Montgomery came to the USA from France in 2000 to join Genset in their R&D department, focusing on the identification of Obesity and Diabetes cure candidates. She received both her Pharm.D and her Ph.D. in Life Science from the University of Bordeaux (France), with emphasis on molecular biology, biology of aging and thrombosis and hemostasis. She has now a solid experience in leading and managing projects in the Life Science Industry in Start-up and large companies involving reagents, large or small instrumentation as well as software.
Jacobs School Faculty Update Your Profile